Singapore and Hong Kong ink MoU on health product regulation

The agreement covers pharmaceuticals, medical devices, and traditional medicine.

Singapore's Health Sciences Authority (HSA) and Hong Kong’s Department of Health (DoH) have signed a memorandum of understanding (MoU) to cooperate on regulatory matters concerning health products.

The agreement covers technical cooperation and the exchange of information, best practices, and expertise across products such as pharmaceuticals, medical devices, therapy products, and traditional medicines.

The MoU also includes the sharing of regulatory information and enforcement approaches for tobacco products and vaping devices.

Moreover, it enables exchange of regulatory experts and staff, participation in meetings and scientific conferences, and collaboration in training courses and joint projects.

The MoU was signed by HSA CEO, Raymond Chua and the Director of Health, Hong Kong DoH, Ronald Lam.

Follow the link for more news on

partnership

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia